User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 16 results.
    • Journal article
    Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
    Eng, Cathy Kim, Tae Won Bendell, Johanna Argilés, Guillem Tebbutt, Niall C Di Bartolomeo, Maria Falcone, Alfredo Fakih, Marwan Kozloff, Mark Segal, Neil H Sobrero, Alberto Yan, Yibing Chang, Ilsung Uyei, Anne Roberts, Louise Ciardiello, Fortunato Ahn, JB Asselah, J Badarinath, S Baijal, S Begbie, S Berry, S Canon, JL Carbone, RG Cervantes, A Cha, YJ Chang, K Chaudhry, A Chmielowska, E Cho, SH Chu, D Couture, F Cultrera, J Cunningham, D Van Cutsem, E Cuyle, PJ Davies, J Dowden, S Dvorkin, M Ganju, V Garcia, RV Kerr, R Kim, TY King, K Kortmansky, J Kozloff, M Lam, KO Lee, J Lee, AS Lesperance, B Luppi, G Ma, B Maiello, E Mandanas, R Marshall, J Marx, G Mullamitha, S Nechaeva, M Park, JO Pavlakis, N Ponce, CG Potemski, P Raouf, S Reeves, J Segal, N Siena, S Smolin, A Streb, JO Strickland, A Szutowicz-Zielinska, E Tabernero, JM Tan, B Valera, JS Van den Eynde, Marc[UCL] Vergauwe, P Vickers, M Womack, M Wroblewska, M Young, R (2019) The Lancet Oncology — Vol. 20, no.6, p. 849-861 (2019)
    • Speech
    Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer: Preliminary analysis of the PePiTA study.
    Hendlisz, Alain Caparica, Rafael Deleporte, Amélie Van Laethem, Jean-Luc Vergauwe, Philippe Van den Eynde, Marc[UCL] Deboever, Guido Janssens, Jozef Demolin, Gauthier Holbrechts, Stephane Clausse, Marylene De Grez, Thierry Vermeij, Joanna D'Hondt, Lionel A. Geboes, Karen Paula Besse-Hammer, Tatiana Buggenhout, Alexis Paesmans, Marianne Piccart, Martine Flamen, Patrick (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (COLORECTAL) CANCER —
    • Speech
    Significant differences in outcome between Immunoscore categories in stage I colon cancer patients
    Galon, J. Hermitte, F. Mlecnik, B. Marliot, F. Bifulco, C. Lugli, A. Nagtegaal, I. Hartmann, A. Van den Eynde, Marc[UCL] Roehrl, M. Ohashi, P. Zavadova, E. Torigoe, T. Patel, P. Wang, Y. Kawakami, Y. Marincola, F. Ascierto, P. Fox, B. Pagès, F. (2019) ESMO Congress 2019 —
    • Speech
    Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors
    Demols, A. Borbath, Ivan[UCL] Van den Eynde, Marc[UCL] Houbiers, G. Peeters, M. Marechal, R. Delaunoit, T. Goeminne, J. Laurent, S. Holbrechts, S. Paesmans, M. Van Laethem, J. (2019) ESMO Congress 2019 —
    • Journal article
    CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
    Rothé, Françoise Maetens, Marion Rouas, Ghizlane Paesmans, Marianne Van den Eynde, Marc[UCL] Van Laethem, Jean-Luc Vergauwe, Philippe Deboever, Guido Bareche, Yacine Vandeputte, Caroline Ignatiadis, Michail Hendlisz, Alain (2019) BMC cancer — Vol. 19, no.1, p. 304 [1-7] (2019)
    • Speech
    Phase 2 study results of murlentamab, a monoclonal antibody targeting the Anti-Mullerian-Hormone-Receptor II (AMHRII), acting through Tumor-Associated Macrophage engagement in advanced/metastatic colorectal cancers
    Van Cutsem, E. Melichar, B. Van den Eynde, Marc[UCL] Prausova, J. Geboes, K. Dekervel, J. Vitaskova, D. De Cuyper, A. Linke, Z. Van Acker, N. Frenois, F. Noel, G. Prost, J. Barret, J. Jean, B. Tabah-Fisch, I. (2019) ESMO Congress 2019 —
    • Speech
    Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients
    Galon, J. Hermitte, F. Mlecnik, B. Marliot, F. Bifulco, C. Lugli, A. Nagtegaal, I. Hartmann, A. Van den Eynde, Marc[UCL] Roehrl, M. Ohashi, P. Zavadova, E. Torigoe, T. Patel, P. Wang, Y. Kawakami, Y. Marincola, F. Ascierto, P. Fox, B. Pagès, F. (2019) Congress European Society for Medical Oncology 2019 —
    • Journal article
    Molecular test algorithms for digestive tumours
    Hébrant, Aline Mourin, Anne[UCL] Froyen, Guy Van der Meulen, Joni de Man, Marc Salgado, Roberto Van den Eynde, Marc[UCL] D'haene, Nicky Martens, Geert Van Cutsem, Eric Antoine-Poirel, Hélène[UCL] Tejpar, Sabine Van Laethem, Jean-Luc Geboes, Karen Pauwels, Patrick Dedeurwaerdere, Francesca Maes, Brigitte De Greve, Jacques Vanhuysse, Jacques Peeters, Pascal Vanacker, Leen Gomez-Galdon, Maria Chintinne, Marie Hendlisz, Alain De Hertogh, Gert Sagaert, Xavier Peeters, Marc Vannuffel, Pascal Lefesvre, Pierre Vermeij, Joanna Simoens, Marc Van den Moorter, Tom Van Damme, Nancy Van den Bulcke Marc (2019) Belgian Journal of Medical Oncology — Vol. 13, no.1, p. 4-10 (2019)
    • Speech
    The consensus Immunoscore adapted to biopsies in patients with locally advanced rectal cancer: Potential clinical significance for a “Watch and Wait” strategy.
    El Sissy, Carine Kirilovsky, Amos Van den Eynde, Marc[UCL] Romero, Alfredo Marliot, Florence Lagorce, Christine Bibeau, Frédéric Iseas, Ilma Soledad Roca, Enrique Luis Vaccaro, Carlos Alberto Tougeron, David Carvalho, Carlos Torres Figueiredo, Nuno Perez, Rodrigo O Habr Gama, Angelita Scripcariu, Viorel Gerard, Jean-Pierre Galon, Jerome Zeitoun, Guy Pages, Franck (2019) Meeting Abstract | 2019 ASCO Annual Meeting I - DEVELOPMENTAL IMMUNOTHERAPY AND TUMOR IMMUNOBIOLOGY —
    • Speech
    An exploratory analysis based on tumor location of REACHIN, a randomized double-blinded placebo-controlled phase II trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tract tumors.
    Demols, Anne Borbath, Ivan[UCL] Van den Eynde, Marc[UCL] Houbiers, Ghislain Peeters, Marc Maréchal, Raphaël Delaunoit, Thierry Goeminne, Jean Charles. Laurent, Stéphanie Holbrechts, Stephane Paesmans, Marianne Van Laethem, Jean-Luc (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (NONCOLORECTAL) CANCER —
    • Journal article
    Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab.
    Köhne, Claus-Henning Karthaus, Meinolf Mineur, Laurent Thaler, Josef Van den Eynde, Marc[UCL] Gallego, Javier Koukakis, Reija Berkhout, Marloes Hofheinz, Ralf-Dieter (2019) Drugs in R&D — Vol. 19, no.3, p. 267-275 (2019)
    • Speech
    Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer
    Van Cutsem, E. Machiels, J. Van den Eynde, Marc[UCL] Prenen, H. Hendlisz, A. Shaza, L. Carrasco, J. Canon, J. Sotiropoulou, P. Breman, E. Alcantar, E. Flament, A. (2019) ESMO Congress 2019 —
    • Speech
    Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS.
    Mansoor, Wasat Arkenau, Hendrik-Tobias ALSINA, MARIA Shitara, Kohei Tejani, Mohamedtaki Abdulaziz Thuss-Patience, Peter C. Cuffe, Sinead Dvorkin, Mikhail Park, David Ando, Takayuki Van den Eynde, Marc[UCL] Beretta, Giordano D. Zaniboni, Alberto Doi, Toshihiko Tabernero, Josep Ilson, David H. Makris, Lukas McGuigan, Sandra Van Cutsem, Eric (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (NONCOLORECTAL) CANCER —
    • Journal article
    Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Fuchs, Charles S Shitara, Kohei Di Bartolomeo, Maria Lonardi, Sara Al-Batran, Salah-Eddin Van Cutsem, Eric Ilson, David H Alsina, Maria Chau, Ian Lacy, Jill Ducreux, Michel Mendez, Guillermo Ariel Alavez, Alejandro Molina Takahari, Daisuke Mansoor, Wasat Enzinger, Peter C Gorbounova, Vera Wainberg, Zev A Hegewisch-Becker, Susanna Ferry, David Lin, Ji Carlesi, Roberto Das, Mayukh Shah, Manish A RAINFALL Study Group Van den Eynde, Marc[UCL] (2019) The Lancet. Oncology — , p. [1-16] (2019)
    • Speech
    Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tumors: A randomized double-blinded placebo-controlled phase II trial.
    Demols, Anne Borbath, Ivan[UCL] Van den Eynde, Marc[UCL] Houbiers, Ghislain Peeters, Marc Maréchal, Raphael Delaunoit, Thierry Goeminne, Jean Charles. Laurent, Stéphanie Holbrechts, Stephane Paesmans, Marianne Van Laethem, Jean L. (2019) ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium — (United States) San Francisco, CA
    • Speech
    Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.
    Galon, Jerome Hermitte, Fabienne Mlecnik, Bernhard Marliot, Florence Bifulco, Carlo Bruno Lugli, Alessandro Nagtegaal, Iris D. Hartmann, Arndt Van den Eynde, Marc[UCL] Roehrl, Michael H. A. Ohashi, Pamela S Zavadova, Eva Torigoe, Toshihiko Patel, Prabhudas S. Wang, Yili Kawakami, Yutaka Marincola, Francesco Ascierto, Paolo Antonio Fox, Bernard A. Pages, Franck (2019) ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium — (United States) San Francisco, CA